Concepedia

Publication | Open Access

Ghost Authorship in Industry-Initiated Randomised Trials

DOIFull Paper Access

286

Citations

14

References

2007

Year

Peter C Gøtzsche, Asbjørn Hróbjartsson, Helle Krogh Johansen, Mette T. Haahr, Douglas G. Altman, An‐Wen Chan
PLoS Medicine

Abstract

Ghost authorship in industry-initiated trials is very common. Its prevalence could be considerably reduced, and transparency improved, if existing guidelines were followed, and if protocols were publicly available.

References

YearCitations

Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials

An‐Wen Chan, Asbjørn Hróbjartsson, Mette T. Haahr,

JAMA

2004

1.8K

Uneasy Alliance — Clinical Investigators and the Pharmaceutical Industry

Thomas Bodenheimer

New England Journal of Medicine

2000

771

Association of Funding and Conclusions in Randomized Drug Trials

Bodil Als‐Nielsen, Wendong Chen, Christian Gluud,

JAMA

2003

728

When authorship fails. A proposal to make contributors accountable

Drummond Rennie

JAMA

1997

572

Prevalence of Articles With Honorary Authors and Ghost Authors in Peer-Reviewed Medical Journals

Annette Flanagin

JAMA

1998

551

Prevalence of Honorary and Ghost Authorship in Cochrane Reviews

G Mowatt

JAMA

2002

229

Interface between authorship, industry and science in the domain of therapeutics

David Healy, Dinah Cattell

The British Journal of Psychiatry

2003

217

Good publication practice for pharmaceutical companies

Elizabeth Wager, Elizabeth A. Field, Leni Grossman

Current Medical Research and Opinion

2003

148

How Statistical Expertise Is Used in Medical Research

Douglas G. Altman

JAMA

2002

129

Haunted Manuscripts: Ghost Authorship in the Medical Literature

Stephanie Ngai, Jennifer Gold, Sudeep S. Gill,

Accountability in Research

2005

74

Page 1